$IBM(IBM.US)

IBM: Reset, Not Breakdown

IBM’s US$67 billion post-earnings wipeout looks dramatic, but the fundamental story is more nuanced. Q2 revenue reached US$17.2 billion, with Software still growing 5%, Red Hat 11% and Data 19%. However, flat Consulting and a 7% Infrastructure decline forced management to cut FY2026 constant-currency revenue-growth guidance to 4–5%. (IBM Newsroom)

The technical picture argues against chasing the rebound. IBM remains below its ~US$244.50 200-day moving average, although the ~US$229 50-day average provides an important near-term reference. (Investing.com)

Valuation is more attractive after the collapse, but not yet compelling enough to ignore execution risk. FY2026 consensus EPS is approximately US$12.33, while the analyst target averages around US$245, with an unusually wide US$174–350 range. (StockAnalysis)

Verdict: ACCUMULATE selectively. IBM remains a quality cash-generative AI/hybrid-cloud franchise, but investors should demand evidence that delayed software spending converts into H2 growth.

For option writers, cash-secured puts below major support offer a superior entry mechanism to outright buying, provided the premium adequately compensates for the risk of another valuation reset.

Not financial advice.